Septerna Inc. Common Stoc... (SEPN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
16.99
0.03 (0.18%)
At close: Jan 15, 2025, 3:59 PM
17.00
0.06%
After-hours Jan 15, 2025, 04:00 PM EST
Company Description
No Company description available at the moment.
Septerna Inc. Common Stock
Country | n/a |
IPO Date | n/a |
Industry | n/a |
Sector | n/a |
Employees | 68 |
CEO | Dr. Jeffrey T. Finer M.D., Ph.D. |
Contact Details
Address: No Address available No city data available, | |
Website | n/a |
Stock Details
Ticker Symbol | n/a |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | n/a |
CIK Code | n/a |
CUSIP Number | 81734D104 |
ISIN Number | US81734D1046 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Dr. Jeffrey T. Finer M.D., Ph.D. | Co-Founder, Chief Executive Officer, President & Director |
Elizabeth P. Bhatt M.B.A., M.S. | Chief Operating Officer |
Ran Xiao C.F.A., M.B.A. | Interim Chief Financial Officer and Vice President of Finance & Business Operations |
Samira Shaikhly | Chief People Officer |
Dr. Arthur Christopoulos BPHARM, Ph.D. | Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board |
Dr. Daniel Long DPHIL | Senior Vice President of Drug Discovery |
Dr. Patrick Sexton Ph.D. | Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board |
Dr. Robert J. Lefkowitz M.D. | Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board |
Richard Hansen Ph.D. | Vice President of Technology |
Uwe Klein Ph.D. | Senior Vice President of Biological Sciences |